Reliability of IBP Criteria & Activity Scores in Patients With AxSpA

NCT05327140 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2023-01-25

No results posted yet for this study

Summary

The current ASAS classification of AxSpA relies either on sacroiliitis on imaging plus one SpA feature (imaging arm) or HLA-B27 antigen plus two SpA features (clinical arm), in a patient with chronic back pain and age at onset of less than 45 years. IBP which is a major symptom of SpA depends more on patient's perception which is not usually accurate. As well, disease activity is measured by ASDAS, BASDAI, and BASFAI which depend more on subjective measures. Assessment of reliability of IBP criteria, ASDAS, BASDAI, and BASFAI in diagnosis and evaluation of activity of AxSpA is essential for better health care.

Conditions

  • Axial Spondyloarthritis
  • Inflammatory Back Pain

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Principal Investigators

  • Eman El-shahawy · Zagazig University

  • Mohamed Mortada · Zagazig University

  • Safaa Elnaggar · Zagazig University

  • Noha Hamed · Zagazig University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-20
Primary Completion
2022-02-22
Completion
2022-05-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05327140 on ClinicalTrials.gov